A survey of the prevalence, management and outcome of infants with an inconclusive diagnosis following newborn bloodspot screening for cystic fibrosis (CRMS/CFSPID) in six Italian centres

Author(s):  
Vito Terlizzi ◽  
Laura Claut ◽  
Antonella Tosco ◽  
Carla Colombo ◽  
Valeria Raia ◽  
...  
2018 ◽  
Vol 17 ◽  
pp. S63-S64
Author(s):  
R.E. Armstrong ◽  
L. Frith ◽  
F.M. Ulph ◽  
K.W. Southern

2020 ◽  
Vol 6 (2) ◽  
pp. 40 ◽  
Author(s):  
Rachael E. Armstrong ◽  
Lucy Frith ◽  
Fiona M. Ulph ◽  
Kevin W. Southern

Newborn bloodspot screening for cystic fibrosis is a valid public health strategy for populations with a high incidence of this inherited condition. There are a wide variety of approaches to screening and in this paper, we propose that a bioethical framework is required to determine the most appropriate screening protocol for a population. This framework depends on the detailed evaluation of the ethical consequences of all screening outcomes and placing these in the context of the genetic profile of the population screened, the geography of the region and the healthcare resources available.


2020 ◽  
Vol 6 (3) ◽  
pp. 56
Author(s):  
Jürg Barben ◽  
Kevin W. Southern

The introduction and widespread implementation of newborn bloodspot screening (NBS) for cystic fibrosis (CF) has offered earlier diagnosis and better outcomes for children with CF in many countries of the world [...]


2019 ◽  
Vol 18 (6) ◽  
pp. 778-780 ◽  
Author(s):  
K.W. Southern ◽  
J. Barben ◽  
S. Gartner ◽  
A. Munck ◽  
C. Castellani ◽  
...  

2019 ◽  
Vol 18 ◽  
pp. S70
Author(s):  
L. Mohammed Abdul Wajid ◽  
P. Barton ◽  
D. Morrison ◽  
E. Burrows ◽  
K.W. Southern

2019 ◽  
Vol 5 (2) ◽  
pp. 23 ◽  
Author(s):  
Faye Johnson ◽  
Kevin W. Southern ◽  
Fiona Ulph

Genetic results of uncertain clinical significance are being returned to parents following newborn screening, representing a paradigm change in how society considers health and illness. ‘Cystic Fibrosis screen positive, inconclusive diagnosis’ (CFSPID) is a designation given to newborns with a positive screening result for, but not a definitive diagnosis of, cystic fibrosis. We explored the psychological impact of receiving a CFSPID result on parents. Five semi-structured interviews were conducted with eight parents whose children have CFSPID. Interpretative phenomenological analysis identified these themes: “The way we were told”: ‘diagnosis as a traumatic event’ focused on how parents were distressed and dissatisfied by the initial screening result communication, ‘Facing and challenging traditional ideas about health and illness’ explored the emerging problem of how CFSPID does not fit the commonly accepted medical model, and ‘Making certainty out of uncertainty’ explored the varying strategies parents developed to adapt to the uncertainty regarding their child’s prognosis. Findings suggest that CFSPID results caused parents’ distress, initiated with the first communication of the result and persisting thereafter. Our data suggests approaches to the delivery of CFSPID results that may reduce the impact. Work is needed to close the gap between healthcare advances and societies commonly held medical model.


Sign in / Sign up

Export Citation Format

Share Document